Editorial ArticleClinical Diagnostics
Fujirebio integration of ADx NeuroSciences expands neurodiagnostic biomarker capabilities
Fujirebio Europe N.V. explains how the full integration of ADx NeuroSciences strengthens its end-to-end model for neurological biomarker development, from early discovery to routine clinical application

















